Advertisement
There is dramatic seasonal variation in rates of admissions for chronic obstructive pulmonary disease exacerbation

CHEST: Admissions, Deaths for COPD Vary by Season

0
Longer length of stay, higher hospital charges seen in January, February, March
Teen use of both flavored and nonflavored tobacco decreases with enforced flavored tobacco restriction policies

Bans on Flavored Products Can Cut Any Tobacco Use in Teens

0
Reduced availability, decreased youth use seen within six months of policy's implementation
The Tailored

Family Involvement Cuts Postop Delirium in Older Patients

0
Patients in elder life program had less decline in physical and cognitive function, shorter length of stay
Eonsmoke LLC has been ordered to halt illegal sales of 100 unapproved flavored vaping products in the United States

FDA: N.J. Company Must Stop Selling Unapproved Flavored Vaping Products

0
Eonsmoke vaping products include flavors such as mango, cotton candy, and sour gummy worm
More than 1

CDC: Cases of Vaping-Linked Lung Illness Now Top 1,600

0
Related death toll has also risen to 34 fatalities, spread across 24 states
Use of ex vivo lung perfusion-treated lungs increases the number of patients undergoing transplantation with comparable long-term outcomes

Lung Transplant With Ex Vivo Lung Perfusion Feasible

0
Method increases number of available lungs with comparable patient outcomes
In predominantly English-speaking settings

Limited English Proficiency May Worsen Chronic Disease Outcome

0
Findings seen in patients discharged from academic medical centers in Toronto with COPD or heart failure
First use of a flavored tobacco product is associated with increased risk for subsequent tobacco use

First Use of Flavored Tobacco Linked to Subsequent Use

0
First use of menthol, mint, or other flavored cigarette versus nonflavored cigarette tied to later cigarette use
Routine

CHEST: Flu Shots Benefit Patients Hospitalized With Pneumonia

0
Study shows that in-hospital influenza vaccination may lower costs, risk for readmission or death
U.S. health groups are slamming the U.S. Food and Drug Administration's decision to permit the General brand of the smokeless tobacco product snus to claim that it poses a "lower risk of mouth cancer

FDA: Smokeless Tobacco Snus Can Be Marketed as Less Risky Than Cigarettes

0
This is the first time the FDA has allowed product marketing of this type